Quest Management Inc. Signs Letter of Intent to Acquire Immunotherapy Biotech Company Stemvax, Inc – Yahoo Finance
|
Quest Management Inc. Signs Letter of Intent to Acquire Immunotherapy Biotech Company Stemvax, Inc
Yahoo Finance MADONA, Latvia, April 11, 2017 (GLOBE NEWSWIRE) — Quest Management Inc. (QSMG) announces the signing of a Letter of Intent (the “Agreement”) to acquire immunotherapy Biotech company Stemvax, Inc., from Dr. Dwain Morris-Irvin PhD. Upon Closing … |
